Met Life Investment Management, LLC Sesen Bio, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.77 - $4.91 $50,411 - $321,452	-65,469 Closed	0 $0
Q2 2021 May 17, 2024	BUY	$2.18 - $4.66 $142,722 - $305,085	65,469 New	65,469 $302,000
Q2 2021 Jun 21, 2023	BUY	$2.18 - $4.66 $142,722 - $305,085	65,469 New	65,469 $302,000
Q2 2021 Mar 22, 2023	BUY	$2.18 - $4.66 $142,722 - $305,085	65,469 New	65,469 $302,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $142,722 - $305,085	65,469 New	65,469 $302,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.